Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001235802-23-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-17 | 2023-08-15 | XTNT | Browne Sean E | Pres, CEO, Dir | A - Grant | $0.00 | +174.2K | 1.68M | +12% | $0 |
| D | 2023-08-17 | 2023-08-15 | XTNT | Browne Sean E | Pres, CEO, Dir | A - Grant | $0.00 | +203.3K | 203.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | A | A | 174,216 | $0.00 | 1,680,800 | D | — | — | (F1) These shares will vest and be issued with respect to 43,554 shares on each of August 15, 2024, August 15, 2025, August 15, 2026 and August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. (F2) Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 866,048 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. |
| 2 | Derivative | Stock Option (right to buy) | 2023-08-15 | A | A | 203,252 | $0.00 | 203,252 | D | $1.20 · — to 2033-08-15 | 203,252 Common Stock | (F3) This option vests with respect to 50,813 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. |